Satoshi Saida

Exchange transfusion and systemic corticosteroid therapy for transient abnormal myelopoiesis in patients with Down syndrome: a report from the JCCG TAM-10 trial.

Journal: European journal of pediatrics

Published: May 24, 2026

Feasibility and Efficacy of Lorlatinib in Japanese Patients With Relapsed/Refractory ALK-Aberrant Neuroblastoma.

Journal: Pediatric blood & cancer

Published: May 07, 2026

Stepwise malignant transformation from MHL to UESL via activation of C19MC and loss of TP53.

Journal: NPJ precision oncology

Published: February 14, 2026

Combination of oral temozolomide and etoposide as palliative chemotherapy for recurrent or progressive neuroblastoma.

Journal: Pediatric hematology and oncology

Published: January 06, 2026

Multi-omics analysis of pediatric minimally differentiated acute myeloid leukemia reveals RUNX1-driven stemness and chemoresistance.

Journal: Leukemia

Published: November 01, 2025

Clinical and molecular characterization of thrombocytosis in transient abnormal myelopoiesis.

Journal: Leukemia

Published: October 23, 2025

Identification of cellular hierarchy in paediatric acute myeloid leukaemia: The Japan Children's Cancer Group trial (JCCG AML-12).

Journal: British journal of haematology

Published: September 12, 2025

Successful venetoclax and azacitidine treatment in pediatric acute myeloid leukemia associated with familial platelet disorder.

Journal: Pediatrics international : official journal of the Japan Pediatric Society

Published: August 08, 2025

Clinical Impact of Immunoglobulin Heavy Chain Clonality in Pediatric B-Cell Precursor Acute Lymphoblastic Leukemia.

Journal: Cancer medicine

Published: August 01, 2025

Concurrent Immune Thrombocytopenia and Autoimmune Neutropenia in a 4-Year-Old Male Patient With XIAP Deficiency: A Case Report.

Journal: Pediatric blood & cancer

Published: June 15, 2025

Exchange transfusion and systemic corticosteroid therapy for transient abnormal myelopoiesis in patients with Down syndrome: a report from the JCCG TAM-10 trial.

Exchange transfusion and systemic corticosteroid therapy for transient abnormal myelopoiesis in patients with Down syndrome: a report from the JCCG TAM-10 trial.

Feasibility and Efficacy of Lorlatinib in Japanese Patients With Relapsed/Refractory ALK-Aberrant Neuroblastoma.

Feasibility and Efficacy of Lorlatinib in Japanese Patients With Relapsed/Refractory ALK-Aberrant Neuroblastoma.

Stepwise malignant transformation from MHL to UESL via activation of C19MC and loss of TP53.

Stepwise malignant transformation from MHL to UESL via activation of C19MC and loss of TP53.

Combination of oral temozolomide and etoposide as palliative chemotherapy for recurrent or progressive neuroblastoma.

Combination of oral temozolomide and etoposide as palliative chemotherapy for recurrent or progressive neuroblastoma.

Multi-omics analysis of pediatric minimally differentiated acute myeloid leukemia reveals RUNX1-driven stemness and chemoresistance.

Multi-omics analysis of pediatric minimally differentiated acute myeloid leukemia reveals RUNX1-driven stemness and chemoresistance.

Clinical and molecular characterization of thrombocytosis in transient abnormal myelopoiesis.

Clinical and molecular characterization of thrombocytosis in transient abnormal myelopoiesis.

Identification of cellular hierarchy in paediatric acute myeloid leukaemia: The Japan Children's Cancer Group trial (JCCG AML-12).

Identification of cellular hierarchy in paediatric acute myeloid leukaemia: The Japan Children's Cancer Group trial (JCCG AML-12).

Successful venetoclax and azacitidine treatment in pediatric acute myeloid leukemia associated with familial platelet disorder.

Successful venetoclax and azacitidine treatment in pediatric acute myeloid leukemia associated with familial platelet disorder.

Clinical Impact of Immunoglobulin Heavy Chain Clonality in Pediatric B-Cell Precursor Acute Lymphoblastic Leukemia.

Clinical Impact of Immunoglobulin Heavy Chain Clonality in Pediatric B-Cell Precursor Acute Lymphoblastic Leukemia.

Concurrent Immune Thrombocytopenia and Autoimmune Neutropenia in a 4-Year-Old Male Patient With XIAP Deficiency: A Case Report.

Concurrent Immune Thrombocytopenia and Autoimmune Neutropenia in a 4-Year-Old Male Patient With XIAP Deficiency: A Case Report.

CAR-T cells with the CD38-CD73-Tim-3-HLA-DR+ phenotype predict the efficacy of tisagenlecleucel as a treatment for B cell precursor ALL.

CAR-T cells with the CD38-CD73-Tim-3-HLA-DR+ phenotype predict the efficacy of tisagenlecleucel as a treatment for B cell precursor ALL.

In Reply to Saraei and Hosseini.

In Reply to Saraei and Hosseini.